News FDA rejects Pfizer Herceptin biosimilar, wants technical inf... A Pfizer-produced biosimilar of Roche’s blockbuster breast cancer drug, Herceptin, has been rejected by US regulators.
News AZ's Tagrisso approved for untreated lung cancer in US Tagrisso outperformed first-generation TKI drugs in FLAURA trial
News VC digital health funding reached record $2.5bn in Q1 Roche's $1.9bn Flatiron Health buy was standout deal
News Roche haemophilia drug gets fast FDA review in expanded use The FDA has granted ‘Breakthrough Therapy’ status for Roche’s Hemlibra (emicizumab) for people with haemophilia A without factor VIII inhibitors, as the Swiss firm aims to take market share
Partner Content Partner Content SMi’s Injectable Drug Delivery Releases an Exclusive Intervi... Injectable Drug Delivery 2018
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.